Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)
CAPS Rating:
A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.
RSS Headlines
Fool UK
Recs
more and more horse trainers and pro sport players arre looking into stem cell its a rocket about to take off.